RECRUITING

Omega-3 Supplementation for Pediatric Migraine

Description

The purpose of the study is to assess the biochemical and clinical effects of omega-3 polyunsaturated fatty acid (PUFA) supplementation in youth suffering from migraine, including its effects on migraine disability, psychological distress, and overall quality of life. This study duration 12 weeks.

Conditions

Study Overview

Study Details

Study overview

The purpose of the study is to assess the biochemical and clinical effects of omega-3 polyunsaturated fatty acid (PUFA) supplementation in youth suffering from migraine, including its effects on migraine disability, psychological distress, and overall quality of life. This study duration 12 weeks.

Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids in Pediatric Migraine Patients

Omega-3 Supplementation for Pediatric Migraine

Condition
Migraine
Intervention / Treatment

-

Contacts and Locations

Chapel Hill

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States, 27599

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Males and females between the ages of 10 and 17 years
  • * Parent consent and subject assent
  • * Diagnosis of migraine based on the third edition of the International Classification of Headache Disorders (ICHD-3) criteria
  • * Known allergy to fish or seafood
  • * Current use of an omega-3 dietary supplement
  • * Significant neurological or psychiatric disorders or developmental delays
  • * Non-English speaking
  • * Allergy to coconut
  • * Pregnancy

Ages Eligible for Study

10 Years to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of North Carolina, Chapel Hill,

Caroline Sawicki, DDS, PhD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

2026-03